Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,746 | -22,238 | -11,620 | -66,727 | -54,637 |
| Depreciation Amortization | 914 | 586 | 322 | 1,380 | 1,056 |
| Accounts payable and accrued liabilities | 216 | 555 | 1,525 | -320 | 410 |
| Other Working Capital | 152 | 582 | 615 | -1,035 | -1,270 |
| Other Operating Activity | 2,280 | 1,277 | -333 | 31,701 | 29,371 |
| Operating Cash Flow | $-26,184 | $-19,238 | $-9,491 | $-35,001 | $-25,070 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66 | -18 | -11 | -89 | -69 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 2,145 |
| Other Investing Activity | 0 | 0 | 0 | 2,145 | 0 |
| Investing Cash Flow | $-66 | $-18 | $-11 | $2,056 | $2,076 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 7,000 | 2,918 | 2,918 |
| Debt Issued | N/A | N/A | N/A | 11,874 | 11,910 |
| Debt Repayment | N/A | N/A | N/A | -11,383 | -11,383 |
| Common Stock Issued | N/A | N/A | N/A | 47,741 | 47,741 |
| Other Financing Activity | 8,500 | 7,000 | 0 | -362 | -238 |
| Financing Cash Flow | $8,500 | $7,000 | $7,000 | $50,788 | $50,948 |
| Beginning Cash Position | 42,567 | 42,567 | 42,567 | 24,724 | 24,724 |
| End Cash Position | 24,817 | 30,311 | 40,065 | 42,567 | 52,678 |
| Net Cash Flow | $-17,750 | $-12,256 | $-2,502 | $17,843 | $27,954 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,184 | -19,238 | -9,491 | -35,001 | -25,070 |
| Capital Expenditure | -66 | -18 | -11 | -89 | -69 |
| Free Cash Flow | -26,250 | -19,256 | -9,502 | -35,090 | -25,139 |